Vaccine effectiveness of the BNT162b2 mRNA COVID-19 vaccine against RT-PCR confirmed SARS-CoV-2 infections, hospitalisations and mortality in prioritised risk groups

Hanne-Dorthe Emborg, Palle Valentiner-Branth, Astrid Blicher Schelde, Katrine Finderup Nielsen, Mie Agermose Gram, Ida Rask Moustsen-Helms, Manon Chaine, Ulla Holten Seidelin, Jens Nielsen
doi: https://doi.org/10.1101/2021.05.27.21257583

Article usage

Article usage: June 2021 to November 2024

AbstractFullPdf
Jun 2021557330859
Jul 202153414181
Aug 2021134236169
Sep 202185449220
Oct 2021827179252
Nov 202141652401
Dec 202133728182
Jan 202232432131
Feb 202254617125
Mar 20222831362
Apr 20222461779
May 2022242769
Jun 2022159851
Jul 2022169638
Aug 20221491851
Sep 2022145537
Oct 2022152334
Nov 202283319
Dec 202280730
Jan 20231021130
Feb 2023881331
Mar 2023106113
Apr 2023123525
May 202370227
Jun 202366512
Jul 202360210
Aug 2023641315
Sep 20232811127
Oct 2023183213
Nov 202369628
Dec 20234328
Jan 20243519
Feb 202450916
Mar 202445314
Apr 202445428
May 202442442
Jun 202448413
Jul 202450423
Aug 202444922
Sep 202454315
Oct 202454326
Nov 202468412
Back to top
Posted June 02, 2021.
Download PDF
Data/Code
Email
Vaccine effectiveness of the BNT162b2 mRNA COVID-19 vaccine against RT-PCR confirmed SARS-CoV-2 infections, hospitalisations and mortality in prioritised risk groups
Hanne-Dorthe Emborg, Palle Valentiner-Branth, Astrid Blicher Schelde, Katrine Finderup Nielsen, Mie Agermose Gram, Ida Rask Moustsen-Helms, Manon Chaine, Ulla Holten Seidelin, Jens Nielsen
medRxiv 2021.05.27.21257583; doi: https://doi.org/10.1101/2021.05.27.21257583
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area